MENU
SLS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

SELLAS Life Sciences Group (SLS) Earnings Date & Reports

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

SLS is expected to report earnings to rise 19.00% to -8 cents per share on November 12

SELLAS Life Sciences Group SLS Stock Earnings Reports
Q3'25
Est.
$-0.08
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.04
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.04
The last earnings report on May 13 showed earnings per share of -7 cents, beating the estimate of -10 cents. With 1.53M shares outstanding, the current market capitalization sits at 159.64M.
View a ticker or compare two or three
SLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SLS showed earnings on May 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
7 Times Square
Phone
+1 646 200-5278
Employees
16
Web
https://www.sellaslifesciences.com